Ethical aspects of the safety of medicines and other social chemicals |
| |
Authors: | Professor Dennis V. Parke |
| |
Affiliation: | (1) Division of Molecular Toxicology, School of Biological Sciences, University of Surrey, GU2 5XH Guildford, Surrey, UK |
| |
Abstract: | The historical background of the discovery of adverse health effects of medicines, food additives, pesticides, and other chemicals is reviewed, and the development of national and international regulations and testing procedures to protect the public against the toxic effects of these drugs and chemicals is outlined. Ethical considerations of the safety evaluation of drugs and chemicals by human experimentation and animal toxicity studies, ethical problems associated with clinical trials, with the falsification of clinical and toxicological data, and with inadequate experimental methodology, are reviewed, and the ethics of the marketing of drugs and their post-marketing surveillance, are similarly considered. These ethical problems are illustrated with many specific examples, including the drugs neoarsphenamine, chloramphenicol, thalidomide, diethyl stilboestrol and benoxaprofen. |
| |
Keywords: | drug safety evaluation chemical toxicity clinical trials animal experiments data falsification good laboratory practice |
本文献已被 PubMed SpringerLink 等数据库收录! |
|